TAAT™ Prepares to Expand into Canada by Partnering with a British Columbia Life Sciences Firm to Develop and Distribute… Feb 26, 2021
Virginia House and Senate Disagree on Conflicting Cannabis Bills Ahead of Saturday’s Legislative Deadline Feb 26, 2021
DraftKings Reports Fourth Quarter and Full-Year 2020 Results and Raises 2021 Revenue Guidance Feb 26, 2021
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion… Feb 26, 2021
From Facing Life in Prison to CEO: Delic Founder Matt Stang on Cannabis, Psychedelics, and Capitalism Feb 26, 2021
PharmaDrug Files For FDA Orphan Drug Designation For DMT In Kidney Transplantation and Expands on Its Psychedelics… Feb 25, 2021
Insufficient Qualified Healthcare Professionals Prompts Demand for Psychedelic Training Programs Feb 24, 2021
Mydecine Announces Exclusive Partnership and Increased Capabilities with Applied Pharmaceutical Innovation (API) Feb 24, 2021
